ArticleJournal of clinical laboratory analysis2022

AFF3 is a novel prognostic biomarker and a potential target for immunotherapy in gastric cancer.

Yuling Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.